chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A 74 year old female pt was treated with OncoTICE for bladder cancer. On 24Jun, after her fourth installation, she experienced nausea, joint pain, painful urination and frequent urination. Following her fifth installation on 01July04 the symptoms became even more severe, especially the joint pain in her hip. After the sixth installation she reportedly had extreme flu-like symptoms and a 38.3C fever and ached all over on 08Jul04 with severe ongoing joint pain for four days. On 19July she reports a swollen left hand for three days.
Tiredness; Lack of energy; This case was reported by a consumer via call center representative and described the occurrence of tiredness in a 71-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included covid-19 vaccine for prophylaxis.   In December 2021, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On an unknown date, the patient received the a dose of covid-19 vaccine. In December 2021, immediately after receiving Shingrix, the patient experienced tiredness and loss of energy. On an unknown date, the outcome of the tiredness and loss of energy were not recovered/not resolved.   It was unknown if the reporter considered the tiredness and loss of energy to be related to Shingrix.  Additional details were provided as follows: The reporter was patient's wife. The reporter reported that patient experienced tiredness and lack of energy shortly after the Shingrix vaccine. The patient also had the Covid vaccine around the same time so reporter was not sure if patients symptoms were from the Shingrix or Covid vaccine. No other information was provided. Consent for follow up was denied.
Patient became pale and vomited. Complained of dizziness. Taken to an exam room and laid flat. Vital signs were 97.8, HR=120, respirations = 20. The patient felt better after 10 minutes. Was observed for 30 minutes until fully recovered.
A report was received from a health care professional on 10/11/2002, concerning a 57 year old female patient who inadvertently received Fluvirin subcutaneously into her arm on 10/07/2002. The patient had experienced no adverse events at the time of the report. The reporter has assessed the relationship of Fluvirin to the event as unclassifiable. Update (1) 11/22/02: The patient experienced slight soreness. The event resolved on an unknown date.
The Vaccination Team was in the Community at a health event. Client reported not having a flu shot in the past year. Client was administered a flu shot on 10/06/2023. When entering vaccination in (medical record) it was determined the client had received a flu vaccine from another provider on 09/22/2023
Patient was not responsive according to the mother.  She did not respond until she took her outside and shook her hard.  At that time she returned to her normal behavior.
Swollen face and red rash on left arm. Vaccine was administered in the left arm.
This spontaneous report as received from a pharmacist via a company representative refers to a female patient of unknown age. Medical history and concurrent conditions were not reported. In December 2013, "about month ago", the patient was vaccinated with ZOSTAVAX. Dose and lot number were not reported. No co-suspect and concurrent therapies were reported. The pharmacist reported that the patient developed an injection site reaction with redness and swelling (approximately in December 2013) and one month later, the injection site was still swollen. At the time of this report the outcome was not recovered. The causality was not reported. Additional information is not expected.
Shortly after getting the vaccine, he developed a cough and green mucus and drainage from his nose. His behavior was normal and we just watched it. It didn't get worse or better. He continues to have a cough and mucus out of his nose today. On July 19, he was diagnosed with pink eye. July 17-19 he had discharge from his eye, but they never turned pink. The doctor said he also had an ear infection. He was given amoxicillin-clav for 10 days. Right after he was given his last dose, he developed a fever. This whole past weekend he had a fever with the highest at 103. We did bring him back to the doctor on Monday and he still had an ear infection. He was given a new antibiotic and we switched for 1-2 days. Then he developed a rash on his body. We went back to the doctor yesterday and we switched the antibiotic again. Today, he seems to be doing better but he still had some of the rash. The doctor said it may have been viral or a reaction to the 2nd antibiotic. Today he was better enough to go back to day care and this is his third antibiotic.
Random instances of severe nausea, vomiting, diarrhea (no changes in diet/eating habits), major chronic fatigue, recurring headaches
pt recv vax 4JUN97 & devel hives were noted on child abd area;no acute distress;lungs did inc sl w/rales et rhonchi which is typical for this child;no tx initiated;sent to clinic;
Nausea, vomiting, headache, chills, temp 101.6, severe body aches
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. The patient's medical history, concurrent conditions, concomitant medications and drug reactions/allergies were not reported. On or about 03-NOV-2009 the patient was inoculated with the ZOSTAVAX (strength, dose, frequency, route, lot # and expiry date were not reported) by a healthcare provider to obtain permanent prevention and protection against shingles and zoster-related injuries. On unspecified date, the patient was diagnosed with shingles and/or other zoster-related injuries (herpes zoster) after and despite being inoculated with the ZOSTAVAX, and suffered serious physical, emotional, and economic damages as a result of injuries. On or about 13-AUG-2010, the patient was treated by physician for shingles. It was reported that, as a direct and proximate result of ZOSTAVAX, the patient had and would continue to suffer ongoing injuries, including but not limited to mental and physical pain and suffering; extensive medical care and treatment of these injuries. The outcome of the events was unknown. The causality assessment was related. Additional information has been requested.
Male patient 38 year of age immunized in left arm with 0.5ml of Janssen vaccine, after 5 minutes of being in observation area refers to feeling dizzy and with a slightly blurred vision. Immediately proceeds to take the patient to the stretcher to elevate his feet since he was pale and sweaty. He was in that position for a few minutes until the patient reported feeling better. The patient was in observation for 20 additional minutes. Patient is asked if he is feeling better, he responds yes and leaves. After two minutes he returns to the center reporting  feeling pressure on chest and a little dizzy. Dr was called to certified how to proceed  with the patient and she refers to transport him to a closer hospital institution. The patient agreed and contacted his emergency contact to let them know that he would be taken to the hospital. Transferred to hospital at 1:50pm  patient reported feeling phobia of needles.
Mom says he had developed a grape-sized lump on the gums near his molars that was affecting his ability top chew, but the next day that went away and since then he has just been feeling very tired and fatigued.
Systemic: Dizziness / Lightheadness-Severe, Systemic: Flushed / Sweating-Medium, Systemic: Nausea-Severe, Systemic: Vomiting-Medium
After traveling on a plane from another state on 01/05, 5 days later I had mild symptoms including sore throat. I took a home COVID-19 test and tested positive on 01/09/2023 in the morning. I called my physician's office and had a telehealth visit with a physician. I was prescribed PAXLOVID and my wife picked it up later that day. I took the medication and within 48 hours the symptoms went away. 5 days later, I tested negative and have not had any recurring symptoms.
Redness, painful, swollen at injection site. Gave patient ibuprofen and put ice on injection site.
Information has been received from a License Visiting Nurse (L.V.N.) concerning a teenage female who on an unspecified date was vaccinated with her second dose of VARIVAX (Merck) (lot#666733/0066z). On an unspecified date the patient had redness, pruritus and local site reactions. The patient sought unspecified medical attention and was treated with ice pack and comfort measures. On an unspecified date, the patient recovered. This is one of several reports received from the same source. Additional information has been requested.
This spontaneous report as received from a pharmacist refers to a 86-year-old female patient with antibiotics allergy, hypertension and hyperlipidemia. On 30-SEP-2016, the patient was vaccinated with a dose of PNEUMOVAX23, 0.5 ml (lot # and expiration date were not reported). On 02-OCT-2016, the patient experienced pain in the joints. On 04-OCT-2016, the patient began to experienced severe headaches, chills and weakness. The patient did not seek medical attention. No laboratory diagnostics studies were performed and no treatment was given. The outcome of weakness, chills, headache and arthralgia was reported as not recovered/not resolved. The relatedness between the events and PNEUMOVAX 23 was not reported. Additional information has been requested.
Large local reaction to right deltoid, erythema, edema, tenderness to approx 1/2 of upper arm. Systemic symptoms with high fever, severe chills, severe headache and nausea.
Full body rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Full body rash) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     No medical history information was reported.  Concomitant products included VALACICLOVIR HYDROCHLORIDE (VALACYCLOVIR HCL) and PREDNISONE for Eye abnormality NOS, APIXABAN (ELIQUIS), METOPROLOL, TIMOLOL, LATANOPROST, CALCIUM, COLECALCIFEROL (CALCIUM WITH D3), MAGNESIUM and SHARK CARTILAGE for an unknown indication.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Mar-2021, the patient experienced RASH (Full body rash). The patient was treated with PARAFFIN, LIQUID, PETROLATUM, WOOL FAT (EUCERIN [PARAFFIN, LIQUID;PETROLATUM;WOOL FAT]) at an unspecified dose and frequency. At the time of the report, RASH (Full body rash) outcome was unknown. Not Provided          Patient did not experience any itching or any other side effects just a rash all over her torso and down her arms and inner legs. She used Eucerin cream for rash.   This case was linked to MOD-2021-047786 (Patient Link).
Menactra administered to pregnant patient/no AE symptoms; Initial information received on 06-Aug-2019 regarding an unsolicited valid non-serious case received from a non-health professional.   This case involves a 16 years old female patient who was exposed to vaccine MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] while she was pregnant.  Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. The reported Menactra administered to pregnant patient/no AE symptoms occurred at unknown gestation period.  The date of last menstrual period was not reported. The estimated due date is 02-Feb-2020.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  No concomitant therapy was reported.   On 25-Jun-2019, the patient received a 0.5 ml dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE lot U6207AA via intramuscular route in the left deltoid.  Patient did not experience any adverse event.  Additionally, at time of reporting, the outcome of the pregnancy is unknown. Outcome of the pregnancy was reported as Unknown and fetal outcome was reported as Unknown.
Client was given his second Moderna too early. 1st dose was 12/07/2021.
Mother reported child was noted to have bright redness and swelling in left anterior thigh starting 6-8 hours and thriving for forty eight hours.
to ED c/o fatigue, cough, + pneumonia. TX: decadron, remdesivir, zinc, o2 2lpm, lovenox, D-dimer 0.73, CRP 5.25, ferritin 357; d/c'd home on O2
Phone call patient stated that her arm became quite swollen all the way to elbow and had redness also. Patient stated site of injection very itchy. Patient treated self with Gold Bond-was having no problems today. Clinic was closed or she would have come in to be seen.
Patient reports vasovagal syncope (low blood pressure and fell down) occurred at early morning the day following the second dose of Shingrix injection.
Pt 5-7 days after receiving Hepatitis B vaccine 9OCT90 pt developed progressive numbness & tingling in feet, ascending to waist over next 3 days.  Reflexes diminished M.D. dx GBS. Resolved over 1 wk.
Immediate pain to left shoulder, Saw private physician, Tests to determine any damage shoulder, Physical therapy weekly
got the flu; Initial information and live follow up regarding an unsolicited valid non-serious case received on 13-Nov-2020 and 03-Dec-2020 from a consumer (Patient) via social media. Both processed together  This case involves a patient of unknown demographics who got the flu (Influenza), while using INFLUENZA VACCINE.  The patient's medical history, medical treatment, vaccination details, concomitant meidcation and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiry date not reported via an unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient reported that got the shot last year, got the flu(influenza) (unknown latency) following the administration of INFLUENZA VACCINE). This year patient said no to the shot.did not get the flu.  Patient beg to differ. never take the flu shot again.  It was not reported if the patient received a corrective treatment.  At the time of reporting, the outcome of event was unknown.  There will be no information available on batch number for this case.
gastrointestinal problems; nauseous; This is a spontaneous report received from a contactable consumer. The reporter is the patient.  A 20-year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), administered in arm left, administration date 15Apr2021 13:15 (Batch/Lot number: unknown) at the age of 20 years as dose 2, single for COVID-19 immunisation. Relevant medical history included: "Gastroparesis" (unspecified if ongoing); "Known allergies: Sulfa drugs" (unspecified if ongoing). There were no concomitant medications. Vaccination history included: BNT162B2 (dose 1, administered in the left arm, Batch/Lot number: unknown), administration date: 25Mar2021 13:15, when the patient was 20 years old, for COVID-19 immunisation. The following information was reported: GASTROINTESTINAL DISORDER (non-serious) with onset 17Apr2021, outcome "unknown", described as "gastrointestinal problems"; NAUSEA (non-serious) with onset 17Apr2021, outcome "unknown", described as "nauseous". The events "gastrointestinal problems" and "nauseous" were evaluated at the physician office visit. It was unknown if therapeutic measures were taken as a result of gastrointestinal disorder, nausea.  Additional information: The patient and her mom (50) got both of their vaccines at the same time/place. With their second dose, they had normal side effects (not further specified) that went away after two days, but they've had gastrointestinal problems since, going on two weeks now. They're both nauseous and eating anything beside the BRAT diet made them feel even worse.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
12 hours after immunization, redness was noted. 24 hours after immunization, redness was raised, hot to touch, tender to touch. Body aches, headache, nausea, chills occurred from 16 hours post vaccination until 30 hours post vaccination. Tylenol and ibuprofen were helpful.
Severe muscle spasms started under my left shoulder blade after 1st injection, not relating it to the vaccine went to chiropractors thinking it was muscles or bones out of place.  After seeing 3 chiropractors and receiving no help it was suggested to see my family practice doctor.  By then my breathing was severely compromised, my dr. sent me to have a chest x-ray to check for blockages, then sent me to the emergency room where a CT scan was done, EKG which was probably out of whack because of pain and breathing difficulty experienced - IV pain meds were administered.  Breathing became somewhat better when pain was less.  Unrelenting muscle spasms continued, terrible pain in the upper left back and upper chest area, lived on Ibuprofen and tylenol for several days.   On the day of the second vaccination I was scheduled for ultrasound of arteries and veins in legs to check for clots, there were no clots.  Still not realizing the pain was related to the covid vaccine I went ahead with the second vaccination.  Since my arms and shoulders were already in so much pain it was decided the right hip would be the site for the injection.  That same night muscle spasms developed from my hips going up all the way through my back.  I completely lost my appetite and didn't eat anything for about 10 days, lost 15 lbs.   Lost all interest in life, could have cared less if I lived or died.  Again I went back to see my family dr., she prescribed muscle relaxers which didn't help at all.  It was decided to make an appointment with a cardiologist where it was discovered that I have pericarditis or inflammation in my heart.  I am now on medication. It's been a long road to recovery and I won't be taking any other covid vaccinations.
A few weeks after receiving my second vaccine shot I started to experience tremors, shaking, numbness in fingers and toes, muscle spasms and head shaking.  I went to my neurologist for an appointment on 10.27.21 where I was diagnosed with Dystonia.  I had previous auto immune issues but Dystonia symptoms started a few weeks after second vaccine.  My doctor is trying to up my anti seizure medicine (Primedone) to see if that helps.  So far no symptoms have lessened.
Tinnitus, joint and muscular pain. Onset approx. 1 week after 3rd vaccine and ongoing.
This spontaneous report was received from a nurse refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patent was inadvertently vaccinated with an expired dose of RECOMBIVAX HB, intramuscularly, lot # H018691 with expiry date: 27-FEB-2015. No adverse effect reported. No further details provided. Additional information has been requested.
Rash/hives on face, neck, upper chest, arms. Mild itching everywhere else.
Patient was administered vaccine on 10/28/21. Vaccine was moved from Freezer to refrigerator on 9/24/21 and therefore was expired on 10/28/21 at time of administration.  No known adverse reactions have been reported by patient
Patient was given COVID vaccine 5-11 and he is 4 years and 10 months old. No side effects and/or symptoms.
Patient has had pain at injection site and shoulder arthritis since his shot (2 months ago). He states that he can't lift his arm past his shoulder. Patient has not talked to a physician about the problem. I advised him to see his primary care doctor.
Chills, aches & pains, fever - 16 hrs. Dizziness - 3 days sore throat with white spots & redness - 1 1/2 days.
P/C from attending phys reports "cellulitis" 5 inch diameter on Right deltoid from imms given  on Mon 04/26/2004.
pain in my arm; pain on the bicep and shoulder; So painful that I cry; bicep pain; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine (1st dose received on an unknown date).   In February 2022, the patient received the 2nd dose of Shingles vaccine. On an unknown date, less than 5 months after receiving Shingles vaccine, the patient experienced pain in arm, shoulder pain, crying and muscle pain. On an unknown date, the outcome of the pain in arm, shoulder pain, crying and muscle pain were unknown.   It was unknown if the reporter considered the pain in arm, shoulder pain, crying and muscle pain to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 29-JUN-2022 Reporter's Comments: This case reported by patient via interactive digital media. The patient received second shingles shot and had pain in arm ever since.  It was so painful sometimes that he/she cry.  It was on the bicep and often times it felt like it was in his/her shoulder too.  The patient could lift his/her shirt over head. Additional supportive information: Follow-up would not be possible as no contact details available.
can't hear; she can't see with one eye; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DEAFNESS (medically significant), outcome "unknown", described as "can't hear"; BLINDNESS UNILATERAL (medically significant), outcome "unknown", described as "she can't see with one eye". It was mentioned that the patient had an adverse event in the brain, that she could not see with one eye and could not hear, but not specified if it was regarding the vaccine.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
S/p COVID-19 vaccine and COVID-19 test uc reports "not feeling well" upon questions with Childcare translator. UC verbalized feeling dizzy, rapid HR, and weak.
Pt developed larger than usual rash. Was warm to touch. Received KEFLEX from Dr.
PATIENT STATED THAT 30-45 MINUTES AFTER RECEIVING BOTH VACCINES AT THE PHARMACY, SHE STARTED  SWEATING, WEAKNESS, AND SOME BREATHING PROBLEMS. HER DAUGHTER CALLED AN AMBULANCE AND SHE WAS TAKEN TO THE EMERGENCY ROOM. AROUND 5PM ON THE SAME DAY AT THE HOSPITAL, SHE STATED THAT SHE HAD EXPERIENCED HIVES ALL OVER THE BODY. SHE WAS TREATED WITH I.V. STEROIDS, I.V. BENADRYL FOR HIVES AT THE HOSPITAL, AND WAS KEPT AT THE HOSPITAL UNDER OBSERVATION FOR 1 DAY. SHE WAS DISCHARGED NEXT DAY HEALTHY.
Information has received from a registered nurse referring to a patient of unknown age and gender. The patient's pertinent medical history stored (Oka/Merck) VARIVAX (lot # M012990, expiration date 14-MAR-2018, 0.5 ml, once, subcutaneous). The vaccine was exposed to 28 Fahrenheit degree for 2 hours and 10 minutes. No adverse effects were reported. Data logger was involved. There was no prior excursion. This is one of several reports received from the same reporter. Additional information has been requested.
Pain in right arm about 2 inches above the wrist starting the day after vaccination, chest pain in upper right chest two days after, right shoulder and neck pain starting 6 days after.
Severe muscle and joint pain that began a few days after the second dose of the Moderna COVID-19 vaccine.